Susquehanna Fundamental Investments, LLC Atara Biotherapeutics, Inc. Transaction History

Susquehanna Fundamental Investments, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$2.85 - $8.73 $40,318 - $123,503	-14,147 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$8.44 - $16.89 $119,400 - $238,942	14,147 New	14,147 $131,000
Q4 2021 Feb 14, 2022	SELL	$14.7 - $19.89 $160,332 - $216,940	-10,907 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$11.99 - $17.9 $38,128 - $56,921	-3,180 Reduced 22.57%	10,907 $195,000
Q2 2021 Aug 11, 2021	SELL	$12.89 - $16.58 $394,395 - $507,298	-30,597 Reduced 68.47%	14,087 $219,000

Q1 2021 May 17, 2021	BUY	$14.0 - $20.72 $434,476 - $643,024	31,034 Added 227.36%	44,684 $642,000
Q4 2020 Feb 16, 2021	BUY	$12.67 - $26.23 $46,245 - $95,739	3,650 Added 36.5%	13,650 $268,000
Q2 2020 Aug 14, 2020	BUY	$7.53 - $14.93 $75,300 - $149,300	10,000 New	10,000 $146,000

85M

18.4K

51.3K

Ticker ATRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,362,304
Market Cap $728M
Description
Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferat...

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.